An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows

Дата публикации: 14-07-2026 15:01:14

WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday. Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can target the protein have [...]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows	2	7	14-07-2026
2	Scientists May Have Found What Really Triggers Alzheimer’s Disease	2	7	19-06-2026
3	В Британии представили результаты генной терапии от болезни Альцгеймера	5	7	16-07-2026
4	Resetting the body’s rhythm could protect the brain from Alzheimer’s	5	7	01-11-2025
5	Anti-Tau-Therapie verfehlt klinischen Endpunkt – greift die Alzheimer-Therapie zu spät?	0	7	16-07-2026
6	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	7	15-07-2026
7	Препарат восстановил повреждения ДНК при болезни Альцгеймера	6	8	09-07-2026
8	STAT+: Preliminary trial results suggest a path to a safer Alzheimer’s treatment	0	8.03	28-07-2026
9	Science & Medicine: Pursuing precision medicine for Alzheimer's disease	0	7.06	12-07-2026
10	The surprising therapy targeting the liver which could protect brain from Alzheimer's	0	9.85	16-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: www.centralillinoisproud.com.